Latest Articles
Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease - Baishideng Publishing Group
Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease Baishideng Publishing Group
Published: March 23, 2026, 8:02 a.m.
Intraoperative Proctosigmoidoscopy Enhances Safety in Bowel Endometriosis Surgery: Study - Medical Dialogues
Intraoperative Proctosigmoidoscopy Enhances Safety in Bowel Endometriosis Surgery: Study Medical Dialogues
Published: March 19, 2026, 2:45 p.m.
Government reassures public on safety of menstrual products following study detecting endocrine-disrupting chemicals - thestar.co.za
Government reassures public on safety of menstrual products following study detecting endocrine-disrupting chemicals thestar.co.za
Published: March 9, 2026, 11:52 a.m.
Safety of sanitary products: Experts say ‘no clear evidence of harm’ - africannewsagency.com
Safety of sanitary products: Experts say ‘no clear evidence of harm’ africannewsagency.com
Published: March 9, 2026, 4:03 a.m.
Endometriosis stole my ‘normal’ and gave me a lifetime of diagnoses and pain - NOW Toronto
Endometriosis stole my ‘normal’ and gave me a lifetime of diagnoses and pain NOW Toronto
Published: March 4, 2026, 4:08 p.m.
Patient safety expert says she and her family never visit specialists alone - AusDoc
Patient safety expert says she and her family never visit specialists alone AusDoc
Published: March 3, 2026, 7:02 a.m.
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon - TipRanks
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon TipRanks
Published: Feb. 27, 2026, 7:47 p.m.
ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval - TradingView
ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval TradingView
Published: Feb. 27, 2026, 3:34 p.m.
ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion - TradingView
ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion TradingView
Published: Feb. 27, 2026, 2:50 p.m.
dtic Backs Probe into Sanitary Pad Safety Concerns - Devdiscourse
dtic Backs Probe into Sanitary Pad Safety Concerns Devdiscourse
Published: Feb. 27, 2026, 1:17 p.m.
Link copied to clipboard!